Jan 12 (Reuters) - IRLAB Therapeutics AB IRLABa.ST :
* IRLAB PRESENTS APPLICATION OF DEEP LEARNING ON
MULTIDIMENSIONAL
CNS DRUG EFFICACY DATA
* BASED ON MULTIDIMENSIONAL IN VIVO PHENOTYPIC DOSE RESPONSE
PROFILES GENERATED BY IRLAB'S ISP TECHNOLOGY, IT IS FOUND THAT
IN PARTICULAR MULTILAYER PERCEPTRON NETWORKS PERFORM WELL FOR
PREDICTION OF THERAPEUTIC INDICATION AND CLASSIFICATION OF DRUG
CANDIDATES
* METHODOLOGY FURTHER HOLDS PROMISE TO DISCOVER NEW OR
EXPANDED
INDICATIONS FOR BOTH DRUG CANDIDATES AND APPROVED TREATMENTS
WITHIN CENTRAL NERVOUS SYSTEM (CNS)
Source text for Eikon: ID:nWkr8B8qK8
Further company coverage: IRLABa.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))